Ganggang Wang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma.

Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma.

Journal: Cancer letters
Published: September 12, 2025

Omics-driven networks herald a new era of multidimensional therapy for cholangiocarcinoma.

Omics-driven networks herald a new era of multidimensional therapy for cholangiocarcinoma.

Journal: Hepatology communications
Published: July 24, 2025

Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma.

Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma.

Journal: Cell research
Published: May 29, 2025

Targeted metabolomics reveals serum biomarkers and metabolic alterations in cholesterol gallstone patients.

Targeted metabolomics reveals serum biomarkers and metabolic alterations in cholesterol gallstone patients.

Journal: Scientific reports
Published: March 28, 2025

Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2.

Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2.

Journal: Bone research
Published: May 14, 2024

Elucidating the role of S100A10 in CD8+ T cell exhaustion and HCC immune escape via the cPLA2 and 5-LOX axis.

Elucidating the role of S100A10 in CD8+ T cell exhaustion and HCC immune escape via the cPLA2 and 5-LOX axis.

Journal: Cell death & disease
Published: January 10, 2024

PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.

PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.

Journal: European journal of medical research
Published: October 26, 2023

SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis.

SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis.

Journal: Cell death discovery
Published: October 02, 2023

Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer.

Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer.

Journal: Cancer cell international
Published: July 08, 2023

SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer.

SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: July 03, 2023

BMP6 inhibits gastric cancer growth and predicts good prognosis.

BMP6 inhibits gastric cancer growth and predicts good prognosis.

Journal: Journal of gastrointestinal oncology
Published: June 19, 2023

Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment.

Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment.

Journal: NPJ precision oncology
Published: May 08, 2023
Showing 1-12 of 18

Last Updated: 09/26/2026